Interaction of mithramycin with chromatin.
Indian J Biochem Biophys
;
2001 Feb-Apr; 38(1-2): 71-4
Article
Dans Anglais
| IMSEAR
| ID: sea-26445
ABSTRACT
Mithramycin (MTR) is an anti-cancer antibiotic that blocks the macromolecular biosynthesis via reversible interaction with DNA template in the presence of bivalent metal ion such as Mg2+. In absence of DNA, mithramycin forms two types of complexes with Mg2+, complex I (with 11 stoichiometry in terms of MTR Mg2+) and complex II (with 12 stoichiometry in terms of MTR Mg2+). In an eukaryotic system, the drug would interact with chromatin, a protein-DNA complex. We have employed the spectroscopic techniques such as absorption and fluorescence to study the interaction of MTR Mg2+ complexes with rat liver chromatin. In this report, we have shown that the two types of ligands have different binding potentials with the same chromatin. This supports our proposition that complexes I and II, are different molecular species. We have also shown that the histone protein(s) reduce the binding potential and the number of available sites for both ligands.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Liaison aux protéines
/
Rats
/
Spectrométrie de fluorescence
/
Mâle
/
Cinétique
/
Chromatine
/
Histone
/
Mithramycine
/
Inhibiteurs de la synthèse d'acide nucléique
/
Relation dose-effet des médicaments
langue:
Anglais
Texte intégral:
Indian J Biochem Biophys
Année:
2001
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS